Table 2.
Population and Metric Sample Sizes for Each Target Condition
| Condition | Sample Population | Medication Use Sample*(% of Sample Population) | Persistence Sample**(% of Sample Population) | Compliance Sample***(% of Sample Population) |
|---|---|---|---|---|
| Asthma | 232,540 | 122,925 (53%) | 103,799 (45%) | 81,882 (35%) |
| COPD | 65,903 | 27,588 (42%) | 19,377 (29%) | 16,737 (25%) |
| CAD | 157,839 | 112,893 (72%) | 105,322 (67%) | 85,385 (54%) |
| Depression | 29,821 | 12,552 (42%) | 10,264 (34%) | 8509 (29%) |
| Diabetes | 251,074 | 157,247 (63%) | 124,125 (49%) | 119,923 (48%) |
| Heart failure | 34,700 | 27,581 (79%) | 25,919 (75%) | 25,440 (73%) |
| Hyperlipidemia | 929,946 | 421,448 (45%) | 388,280 (42%) | 367,903 (40%) |
| Hypertension | 729,664 | 501,740 (69%) | 469,815 (64%) | 458,043 (63%) |
*
Patients who filled at least 1 medication per guidelines; **Patients who filled at least 1 medication per guidelines and had 6 months of follow-up after first medication fill; **Patients who filled at least 2 medications per guidelines and had 6 months of follow-up after first medication fill.
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.